Symposium on Advances in Molecular Hematology 3: State of the Art Invited Lecture
Published in:
Transfuze Hematol. dnes,22, 2016, No. Supplementum1, p. 31.
Category:
Labels
Haematology Internal medicine Clinical oncologyArticle was published in
Transfusion and Haematology Today
2016 Issue Supplementum1
- Neutralizing Antibodies Against Emicizumab – Detailed Analysis Based on a Case Study
- Position of aPCC in the Treatment of Hemophilia A Complicated by the Development of Inhibitors
- Sport and Physical Activity Benefit Hemophiliacs
- What FVIII Levels Are Ideal for Preventing Bleeding in Hemophilia A?
- Administration of aPCC as a Prevention of Bleeding After Major Cardiac Surgical Procedures
Most read in this issue
- Symposium on Advances in Molecular Hematology 1: Lymphoma Pathogenesis
- Symposium on Advances in Molecular Hematology 2: Stressed Hematopoiesis
- Symposium on Advances in Molecular Hematology 3: State of the Art Invited Lecture